Chronic Myeloproliferative Disorders Terminated Phase Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00253552G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersTreatment